| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $0 | -100.0% | — |
| SG&A Expense | $5K | -43.2% | +238.5% |
| Operating Income | -$112K | +87.2% | -720.0% |
| Pre-tax Income | -$112K | — | -718.2% |
| Income Tax | $0 | — | — |
| Net Income | -$112K | +87.2% | -718.2% |
| EPS (Basic) | $0.00 | +100.0% | — |
| EPS (Diluted) | $0.00 | +100.0% | — |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14K | -89.4% | +8291.5% |
| Current Assets | $14K | -97.2% | +8291.5% |
| Total Assets | $144K | -87.5% | — |
| Current Liabilities | $769K | +6.3% | -68.2% |
| Total Liabilities | $769K | +6.3% | -68.2% |
| Stockholders' Equity | -$625K | -246.3% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$114K | -52.0% | — |
| Capital Expenditures | $71K | — | — |
| Investing Cash Flow | -$71K | — | — |
| Financing Cash Flow | $202K | -1.5% | — |
| Free Cash Flow | -$184K | — | — |
| +74.1% |